Return to study ST003047 main page

MB Sample ID: SA330839

Local Sample ID:WT_C
Subject ID:SU003162
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090

Select appropriate tab below to view additional metadata details:


Subject:

Subject ID:SU003162
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090

Factors:

Local Sample IDMB Sample IDFactor Level IDLevel ValueFactor Name
WT_CSA330839FL039173Wild-typeGenotype

Collection:

Collection ID:CO003155
Collection Summary:Tfamfl/fl mice (Larsson et al., 1998) were provided by Larsson NG (Max Plack Institute for Biology of Ageing, Cologne, Germany) and were crossed at the Centro de Biologia Molecular Severo Ochoa (CBMSO) animal facility with MB1Cre mice (Hobeika et al., 2006). MB1Cre mice were kindly provided by Alarcón B (CBMSO, Madrid, Spain). Mouse colonies were bred at the CBMSO under specific pathogen-free conditions and on C57BL/6 background. Mice were group-housed, have not been used in previous procedures and were fed with standard chow. Littermates were randomly assigned to experimental groups. Male and female between the ages of 8-16 weeks were used for the experiment. Splenic naive B lymphocytes were purified using negative B cell cell isolation kits (Miltenyi Biotec). After 24 hours stimulation, live cells were sorted, pelleted and frozen with liquid N2.
Collection Protocol Filename:Protocol_BL.pdf
Sample Type:B-cells

Treatment:

Treatment ID:TR003171
Treatment Summary:Mice were group-housed and fed with standard chow. B lympchocytes from wild-type and knock-out mice were isolated and cultured for 24 hours in RPMI 1640 supplemented with 10% FCS, 1mM Glutamine, 0,01% sodium pyruvate, 20mM 2-mercaptoethanol, penicillin and streptomycin. Cells were cultured adding interleukine-4 and interleukine-5 at 10 ng/Ml, anti-IgM 1 ug/mL and anti-CD40 0,3 ug/mL.

Sample Preparation:

Sampleprep ID:SP003168
Sampleprep Summary:From wild-type samples WT_A, WT_B and WT_C 5.6 x 106, 6.4 x 106 and 4.87 x 106 B lymphocytes were harvested respectively, and for knock-out samples KO_D, KO_E and KO_F 1.8 x 106, 2.1 x 106 and 1.8 x 106 B lymphocytes were harvested respectively. Cell homogenates were prepared by adding 1:1 v/v water: methanol and sonicated with a dr.hielscher UP200S (dr.hielscher, Berlin, Germany), set up to 80% intensity, 0.5 s/pulse, 16 pulses. For GC-MS, 100 µL of each homogenate was mixed with 300 µL of cold methanol containing 25 ppm D-palmitic acid (internal standard), vortex mixed for 60 min and centrifuged at 4000 g for 20 min. 250 µL of the supernatant were transferred to a vial with a glass insert and evaporated to dryness in a Gyrozen HyperVac VC2124 (Gimpo, Korea) coupled to a LVS 110Z (Gardner Denver Thomas GmbH Welch Vacuum, Fürstenfeldbruck, Germany). The samples were then submitted to methoximation (with O-methoxyamine) for 16 h and silylation for 1 h at 70ºC with N,O-Bis(trime5j,thylsilyl)trifluoroacetamide (BSTFA) and trimethylchlorosilane (TCMS), and finally resuspended in 100 µL heptane.
Sampleprep Protocol Filename:Protocol_BL.pdf

Combined analysis:

Analysis ID AN004998
Analysis type MS
Chromatography type GC
Chromatography system Agilent 8890
Column Agilent DB5-MS (30m x 0.25mm, 0.25um)
MS Type EI
MS instrument type GC-Q-MS
MS instrument name Agilent 5977B
Ion Mode POSITIVE
Units relative abundance

Chromatography:

Chromatography ID:CH003776
Chromatography Summary:For GC-MS, the samples were injected onto a DB5-MS column (30 m x 0.250 mm, 0.25 µm) with a 10 m pre-column (Agilent Technologies, Santa Clara CA, USA). Helium was used as mobile phase at constant flow rate (1 mL/min) in a GC-Q-MS (8890 GC coupled to 5977B MS) system (Agilent Technologies) with an Electron Ionization (EI) source at 70 eV.
Methods Filename:Protocol_BL.pdf
Instrument Name:Agilent 8890
Column Name:Agilent DB5-MS (30m x 0.25mm, 0.25um)
Column Temperature:-60 °C-325/350 °C
Flow Gradient:NA
Flow Rate:1 mL/min
Solvent A:NA
Solvent B:NA
Chromatography Type:GC

MS:

MS ID:MS004738
Analysis ID:AN004998
Instrument Name:Agilent 5977B
Instrument Type:GC-Q-MS
MS Type:EI
MS Comments:Cell homogenates were prepared by adding 1:1 v/v water: methanol and sonicated with a dr.hielscher UP200S (dr.hielscher, Berlin, Germany), set up to 80% intensity, 0.5 s/pulse, 16 pulses. For GC-MS, 100 μL of each homogenate was mixed with 300 μL of cold methanol containing 25 ppm D-palmitic acid (internal standard), vortex mixed for 60 min and centrifuged at 4000 g for 20 min. 250 μL of the supernatant were transferred to a vial with a glass insert and evaporated to dryness in a Gyrozen HyperVac VC2124 (Gimpo, Korea) coupled to a LVS 110Z (Gardner Denver Thomas GmbH Welch Vacuum, Fürstenfeldbruck, Germany). The samples were then submitted to methoximation (with O-methoxyamine) for 16 h and silylation for 1 h at 70ºC with N,O-Bis(trime5j,thylsilyl)trifluoroacetamide (BSTFA) and trimethylchlorosilane (TCMS), and finally resuspended in 100 μL heptane. The samples were injected onto a DB5-MS column (30 m x 0.250 mm, 0.25 μm) with a 10 m pre-column (Agilent Technologies, Santa Clara CA, USA). Helium was used as mobile phase at constant flow rate (1 mL/min) in a GC-Q-MS 5975 system (Agilent Technologies) with an Electron Ionization (EI) source at 70 eV.
Ion Mode:POSITIVE
  logo